Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000950035 | SCV001096313 | benign | not provided | 2018-05-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000950035 | SCV005275050 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000950035 | SCV001929144 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000950035 | SCV001966503 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003960608 | SCV004775015 | likely benign | IRAK1-related disorder | 2019-11-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |